↓ Skip to main content

Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study

Overview of attention for article published in BMC Pharmacology and Toxicology, July 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study
Published in
BMC Pharmacology and Toxicology, July 2017
DOI 10.1186/s40360-017-0164-3
Pubmed ID
Authors

Vanessa Alves-Conceição, Daniel Tenório da Silva, Vanessa Lima de Santana, Edileide Guimarães dos Santos, Lincoln Marques Cavalcante Santos, Divaldo Pereira de Lyra

Abstract

Polypharmacy is a reality in long-term care facilities. However, number of medications used by the patient should not be the only predictor of a complex pharmacotherapy. Although the level of complexity of pharmacotherapy is considered an important factor that may lead to side effects, there are few studies in this field. The aim of this study was to evaluate the complexity of pharmacotherapy in residents of three long-term care facilities. A cross-sectional study was performed to evaluate the complexity of pharmacotherapy using the protocols laid out in the Medication Regimen Complexity Index instrument in three long-term care facilities in northeastern Brazil. As a secondary result, potential drug interactions, potentially inappropriate medications, medication duplication, and polypharmacy were evaluated. After the assessment, the association among these variables and the Medication Regimen Complexity Index was performed. In this study, there was a higher prevalence of women (64.4%) with a high mean age among the study population of 81.8 (±9.7) years. The complexity of pharmacotherapy obtained a mean of 15.1 points (±9.8), with a minimum of 2 and a maximum of 59. The highest levels of complexity were associated with dose frequency, with a mean of 5.5 (±3.6), followed by additional instructions of use averaging 4.9 (±3.7) and by the dosage forms averaging 4.6 (±3.0). The present study evaluated some factors that complicate the pharmacotherapy of geriatric patients. Although polypharmacy was implicated as a factor directly related to complexity, other indicators such as drug interactions, potentially inappropriate medications, and therapeutic duplication can also make the use of pharmacotherapy in such patients more difficult.

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 19%
Student > Master 8 14%
Researcher 7 12%
Student > Ph. D. Student 5 9%
Other 3 5%
Other 9 16%
Unknown 15 26%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 11 19%
Medicine and Dentistry 9 16%
Nursing and Health Professions 7 12%
Biochemistry, Genetics and Molecular Biology 2 3%
Psychology 2 3%
Other 4 7%
Unknown 23 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2018.
All research outputs
#6,212,168
of 19,141,800 outputs
Outputs from BMC Pharmacology and Toxicology
#126
of 373 outputs
Outputs of similar age
#104,857
of 282,214 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#1
of 3 outputs
Altmetric has tracked 19,141,800 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 373 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,214 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them